none Team
MA
Maneesh Arora
Sweet spot: $100K
Range: $25K - $200K
Investors in San Francisco (CA)
Investors in Parenting/Families (Seed), Investors in Messaging (Seed), Investors in Sales & CRM (Seed), Investors in SMB Software (Seed), Investors in Entertainment & Sports (Seed), Investors in Real Estate/PropTech (Seed), Investors in Education (Seed), Investors in E-commerce (Seed), Investors in E-commerce (Seed), Investors in Education (Seed), Investors in FinTech (Seed), Investors in Entertainment & Sports (Seed), Investors in Parenting/Families (Seed), Investors in Messaging (Seed), Investors in SaaS (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in SMB Software (Seed), Investors in Sales & CRM (Seed), Investors in Real Estate/PropTech (Seed), Investors in FinTech (Seed), Investors in SaaS (Seed)
to see your intro paths to Maneesh
Photo of Thomas Cuvelier, none
Thomas Cuvelier
Sweet spot: $1M
Range: $100K - $10.0M
Investors in United States, Investors in France, Investors in Norway, Investors in Denmark, Investors in Sweden, Investors in Finland, Investors in United Kingdom
Investors in Developer Tools (Series A), Investors in Developer Tools (Seed), Investors in Cloud Infrastructure (Series A), Investors in Data Services (Seed), Investors in Cloud Infrastructure (Seed), Investors in Data Services (Series A), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in AI (Seed), Investors in AI (Series A), Investors in Enterprise (Series A), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Seed), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Seed), Investors in Enterprise Infrastructure (Seed), Investors in Enterprise Infrastructure (Series A), Investors in SaaS (Series A), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed)
to see your intro paths to Thomas
Photo of Arthur Polk, none
Arthur Polk
Sweet spot: $10.0M
Range: $1M - $20.0M
Investors in Boston (MA), Investors in San Diego (CA), Investors in New York (NY), Investors in SF Bay Area (CA), Investors in San Francisco (CA)
Investors in Drug Delivery (Series A), Investors in Drug Delivery (Pre-seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Pre-seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Series A), Investors in AI (Seed), Investors in AI (Pre-seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Pre-seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series B), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in AI (Series B), Investors in Diagnostics (Seed), Investors in AI (Pre-seed), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health IT (Series B), Investors in Drug Delivery (Series A), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Pre-seed), Investors in AI (Seed), Investors in Consumer Health (Seed), Investors in AI (Series A), Investors in Digital Health (Seed), Investors in Generative Tech/AI (Pre-seed), Investors in AI (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series B), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Seed), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series A), Investors in AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series B), Investors in Diagnostics (Series A), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Series B), Investors in Pharmaceuticals (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in Generative Tech/AI (Series B), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in AI (Series A), Investors in Drug Delivery (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Consumer Health (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Diagnostics (Series B), Investors in BioTech (Series A), Investors in Consumer Health (Series B), Investors in Digital Health (Pre-seed), Investors in Consumer Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series B), Investors in AI (Series A), Investors in Health IT (Series A), Investors in BioTech (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series B), Investors in BioTech (Pre-seed), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in AI (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Health IT (Series B), Investors in Diagnostics (Seed), Investors in Consumer Health (Pre-seed), Investors in Pharmaceuticals (Series B), Investors in Drug Delivery (Series B), Investors in Generative Tech/AI (Seed), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Pre-seed), Investors in Boston / New England (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Pre-seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Generative Tech/AI (Series B), Investors in Drug Delivery (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Drug Delivery (Seed), Investors in Diverse Investors (Other Lists), Investors in Digital Health (Series A), Investors in Drug Delivery (Series B), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Generative Tech/AI (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Digital Health (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Series A), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in Diagnostics (Seed), Investors in Investors who were founders (Other Lists), Investors in Health & Hospital Services (Seed), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in AI (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health IT (Pre-seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in BioTech (Series B), Investors in AI (Series B), Investors in AI (Series A), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Consumer Health (Series A)
to see your intro paths to Arthur
Photo of Richard Trimble, none
Richard Trimble
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Palo Alto (CA)
to see your intro paths to Richard